Zura Bio Limited
ZURA
$3.51
-$0.21-5.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -19.10% | 6.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.07% | -6.19% | |||
| Operating Income | -8.07% | 6.19% | |||
| Income Before Tax | -12.80% | 8.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.80% | 8.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.80% | 8.31% | |||
| EBIT | -8.07% | 6.19% | |||
| EBITDA | -8.05% | 6.20% | |||
| EPS Basic | -24.94% | 9.59% | |||
| Normalized Basic EPS | -12.45% | 9.63% | |||
| EPS Diluted | -24.94% | 9.59% | |||
| Normalized Diluted EPS | -12.45% | 9.63% | |||
| Average Basic Shares Outstanding | 0.29% | 1.43% | |||
| Average Diluted Shares Outstanding | 0.29% | 1.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||